Table 3.
Associations between patient costs and patients’ depressive symptoms, cognitive complaints, fatigue, and clinical characteristics
| Model | Margins | 95% CI | P-value | No Obs | |
|---|---|---|---|---|---|
| Costs | Predictors | ||||
| Univariate | |||||
| Healthcare utilization costs | Depressive symptoms | 18.343 | 1.026 to 35.659 | 0.009** | 270 |
| Fatigue | 5.491 | − 0.774 to 11.756 | 0.050** | 268 | |
| Cognitive complaints | 6.174 | 0.297 to 12.051 | 0.019** | 266 | |
| Medication costs | Depressive symptoms | − 2.481 | − 5.411 to 0.450 | 0.053** | 278 |
| Cognitive complaints | − 1.889 | − 3.165 to − 0.614 | < 0.001** | 276 | |
| Tumor grade: | 0.015** | 279 | |||
| Low-grade | 53.299 | 31.152 to 75.447 | |||
| High-grade | 109.826 | 65.023 to 154.628 | |||
| Disease status: | < 0.001** | 262 | |||
| Stable | 46.422 | 32.404 to 60.440 | |||
| Active/progression | 164.319 | 92.078 to 236.500 | |||
| Multivariate | |||||
| Healthcare utilization costs | Depressive symptoms | 24.459 | 3.662 to 45.250 | 0.001** | 270 |
| Tumor grade | 182.878 | − 96.438 to 462.190 | 0.170 | ||
| Medication costs | Cognitive complaints | − 0.694 | − 1.505 to 0.117 | 0.078* | 259 |
| Tumor grade | 31.619 | − 5.489 to 68.727 | 0.078* | ||
| Disease status | 76.171 | 29.580 to 122.0761 | < 0.001** | ||
*P < 0.10; **P < 0.05